⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5056758 | 0.83 | RAB9A (0.62) | — | |
| SCHEMBL8040426 | 0.81 | — | — | |
| SCHEMBL27645125 | 0.81 | — | — | |
| SCHEMBL14764287 | 0.79 | CES2 (0.65) | — | |
| SCHEMBL20067208 | 0.79 | — | — | |
| SCHEMBL3798 | 0.79 | — | — | |
| SCHEMBL3338644 | 0.79 | — | — | |
| SCHEMBL8170661 | 0.79 | — | — | |
| SCHEMBL27304431 | 0.79 | — | — | |
| SCHEMBL13811289 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1939920-A | Eastern poppy base compound and its medical use | TOXICOLOGY INST MILITARY MEDIC (CN) | 2007-04-04 | — | — | CN | claimed |
| US-10693073-B2 | Fullerene derivatives and organic electronic device comprising fullerene derivatives | LG CHEM, LTD. (KR) | 2020-06-23 | — | — | US | disclosed |
| US-10270038-B2 | Fullerene derivative, organic solar cell using same, and preparation method therefor | LG CHEM, LTD. (KR) | 2019-04-23 | — | — | US | disclosed |
| EP-3103801-B1 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND PREPARATION METHOD THEREFOR | LG CHEMICAL LTD (KR) | 2018-07-04 | — | — | EP | disclosed |
| EP-3103801-A1 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND PREPARATION METHOD THEREFOR | LG Chem, Ltd. (KR) | 2016-12-14 | — | — | EP | disclosed |
| EP-3093270-A1 | FULLERENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE COMPRISING FULLERENE DERIVATIVES | LG Chem, Ltd. (KR) | 2016-11-16 | — | — | EP | disclosed |
| US-20160329499-A1 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND PREPARATION METHOD THEREFOR | LG CHEM, LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-20160329498-A1 | FULLERENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE COMPRISING FULLERENE DERIVATIVES | LG CHEM, LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| EP-2759008-A1 | TIN OXIDE-CONTAINING POLYMER COMPOSITE MATERIALS | BASF SE (DE) | 2014-07-30 | — | — | EP | disclosed |
| CN-103782422-A | Tin oxide-containing polymer composite materials | BASF SE | 2014-05-07 | — | — | CN | disclosed |
| US-7183296-B2 | Anti-HIV pyrazole derivatives | ROCHE PALO ALTO LLC (US) | 2007-02-27 | — | — | US | disclosed |
| US-20040192752-A1 | Anti-HIV pyrazole derivatives | DYMOCK BRIAN WILLIAM (GB) | 2004-09-30 | — | — | US | disclosed |
| US-6699887-B2 | ADMINISTERING A THERAPEUTICALLY EFFECTIVE AMOUNT OF A PYRRAZOLE SULFIDE OR ETHER COMPOUND TO TREAT THE HUMAN IMMUNODEFICIENCY VIRUS INFECTION | HOFFMANN-LA ROCHE INC. | 2004-03-02 | — | — | US | disclosed |
| EP-1326843-A1 | PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES | F. Hoffmann-La Roche AG (CH) | 2003-07-16 | — | — | EP | disclosed |
| US-20030018197-A1 | Anti-HIV pyrazole derivatives | HOFFMANN-LA ROCHE INC. | 2003-01-23 | — | — | US | disclosed |
| WO-2002030907-A1 | PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-04-18 | — | — | WO | disclosed |
| CN-1003855-B | Process for preparing 1, 3-disubstituted 2-oxindoles | 美国辉瑞有限公司 | 1989-04-12 | — | — | CN | disclosed |
| US-4721712-A | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents | PFIZER INC. (US) | 1988-01-26 | — | — | US | disclosed |
| US-4658037-A | RHEUMATIC DISEASES | PFIZER INC. (US) | 1987-04-14 | — | — | US | disclosed |
| US-4569942-A | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents | PFIZER INC. (US) | 1986-02-11 | — | — | US | disclosed |